Binding of G-quadruplex-interactive agents to distinct G-quadruplexes induces different biological effects in MiaPaCa cells

Nucleosides, Nucleotides and Nucleic Acids

Volumn 24, Issue 10-12, 2005, Pages 1801-1815

  Liu, Weijun ^a   Sun, Daekyu ^a,b   Hurley, Laurence H ^a,b,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c University of Arizona   (United States)

Author keywords

G Quadruplex interactive agent; Telomere; Telomestatin; TMPyP4

Indexed keywords

ANTINEOPLASTIC AGENT; GUANINE DERIVATIVE; TELOMESTATIN;

ANAPHASE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CELL GROWTH; CONCENTRATION (PARAMETERS); CYTOTOXICITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PANCREAS CARCINOMA; SENESCENCE; STRUCTURE ANALYSIS; TELOMERE;

ANAPHASE; ANGIOGENESIS INHIBITORS; APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HUMANS; OXAZOLES; PANCREATIC NEOPLASMS; PORPHYRINS;

EID: 29244487119     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770500267238     Document Type: Article

References (44)

1. Shay, J.W. Aging and cancer: Are telomeres and telomerase the connection? Mol. Med. Today 1995, 1, 378.
2. Holt, S.E.; Shay, J.W.; Wright, W.E. Refining the telomere-telomerase hypothesis of aging and cancer. Nat. Biotechnol. 1996, 14, 836.
3. Miura, T.; Mattson, M.P.; Rao, M.S. Cellular lifespan and senescence signaling in embryonic stem cells. Aging Cell 2004, 3, 333.
4. Wright, W.E.; Shay, J.W. Historical claims and current interpretations of replicative aging. Nat. Biotechnol. 2002, 20, 682.
5. Granger, M.P.; Wright, W.E.; Shay, J.W. Telomerase in cancer and aging. Crit. Rev. Oncol. Hematol. 2002, 41, 29.
6. Shay, J.W.; Zou, Y.; Hiyama, E.; Wright, W.E. Telomerase and cancer. Hum. Mol. Genet. 2001, 10, 677.
7. Shay, J.W. Telomerase in cancer: diagnostic, prognostic, and therapeutic implications. Cancer J. Sci. Am. 1998, 4, S26.
8. Holt, S.E.; Shay, J.W. Role of telomerase in cellular proliferation and cancer. J. Cell. Physiol. 1999, 180, 10.
9. Shay, J.W.; Wright, W.E. Telomerase: a target for cancer therapeutics. Cancer Cell 2002, 2, 257.
10. White, L.K.; Wright, W.E.; Shay, J.W. Telomerase inhibitors. Trends Biotechnol. 2001, 19, 114.
11. Rezler, E.M.; Bearss, D.J.; Hurley, L.H. Telomere inhibition and telomere disruption as processes for drug targeting. Annu. Rev. Pharmacol. Toxicol. 2003, 43, 359.
12. Rezler, E.M.; Bearss, D.J.; Hurley, L.H. Telomeres and telomerases as drug targets. Curr. Opin. Pharmacol. 2002, 2, 415.
13. Mergny, J.L.; Hélène, C. G-quadruplex DNA: a target for drug design. Nat. Med. 1998, 4, 1366.
14. Hurley, L.H.; Wheelhouse, R.T.; Sun, D.; Kerwin, S.M.; Salazar, M.; Fedoroff, O.Yu.; Han, F.X.; Han, H.; Izbicka, E.; Von Hoff, D.D. G-quadruplexes as targets for drug design. Pharmacol. Ther. 2000, 85, 141.
15. Phan, A.T.; Modi, Y.S.; Patel, D.J. Propeller-type parallel-stranded G-quadruplexes in the human c-myc promoter. J. Am. Chem. Soc. 2004, 126, 8710.
16. Parkinson, G.N.; Lee, M.P.; Neidle, S. Crystal structure of parallel quadruplexes from human telomeric DNA. Nature 2002, 417, 876.
17. Riou, J.F. G-quadruplex interacting agents targeting the telomeric G-overhang are more than simple telomerase inhibitors. Curr. Med. Chem. Anti-Canc. Agents 2004, 4, 439.
18. Sun, D.; Thompson, B.; Cathers, B.E.; Salazar, M.; Kerwin, S.M.; Trent, J.O.; Jenkins, T.C.; Neidle, S.; Hurley, L.H. Inhibition of human telomerase by a G-quadruplex-interactive compound. J. Med. Chem. 1997, 40, 2113.
19. Shi, D.-F.; Wheelhouse, R.T.; Sun, D.; Hurley, L.H. Quadruplex- interactive agents as telomerase inhibitors: Synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase. J. Med. Chem. 2001, 44, 4509.
20. Duan, W.; Rangan, A.; Vankayalapati, H.; Kim, M.-Y.; Zeng, Q.; Sun, D.; Han, H.; Fedoroff, O.Yu.; Nishioka, D.; Rha, S.Y.; Izbicka, E.; Von Hoff, D.D.; Hurley, L.H. Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effects. Mol. Cancer Ther. 2001, 1, 103.
21. Leonetti, C.; Amodei, S.; D'Angelo, C.; Rizzo, A.; Benassi, B.; Antonelli, A.; Elli, R.; Stevens, M.F.; D'Incalci, M.; Zupi, G.; Biroccio, A. Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13- trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration. Mol. Pharmacol. 2004, 66, 1138.
22. Li, C.P.; Huang, J.H.; Chang, A.C.; Hung, Y.M.; Lin, C.H.; Chao, Y.; Lee, S.D.; Whang-Peng, J.; Huang, T.S. A G-quadruplex ligand 3,3′- diethyloxadicarbocyanine iodide induces mitochondrion-mediated apoptosis but not decrease of telomerase activity in nasopharyngeal carcinoma NPC-TW01 cells. Pharm. Res. 2004, 21, 93.
23. Gomez, D.; Lemarteleur, T.; Lacroix, L.; Mailliet, P.; Mergny, J.L.; Riou, J.F. Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing. Nucleic Acids Res. 2004, 32, 371.
24. Lemarteleur, T.; Gomez, D.; Paterski, R.; Mandine, E.; Mailliet, P.; Riou, J.F. Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase. Biochem. Biophys. Res. Commun. 2004, 323, 802.
25. Shin-ya, K.; Wierzba, K.; Matsuo, K.; Ohtani, T.; Yamada, Y.; Furihata, K.; Hayakawa, Y.; Seto, H. Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. J. Am. Chem. Soc. 2001, 123, 1262.
26. Riou, J.F.; Guittat, L.; Mailliet, P.; Laoui, A.; Renou, E.; Petitgenet, O.; Megnin-Chanet, F.; Hélène, C.; Mergny, J.L. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 2672.
27. Kim, M.-Y.; Gleason-Guzman, M.; Izbicka, E.; Nishioka, D.; Hurley, L.H. The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures. Cancer Res. 2003, 63, 3247.
28. Shammas, M.A.; Shmookler Reis, R.J.; Akiyama, M.; Koley, H.; Chauhan, D.; Hideshima, T.; Goyal, R.K.; Hurley, L.H.; Anderson, K.C.; Munshi, N.C. Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma. Mol. Cancer Ther. 2003, 2, 825.
29. Izbicka, E.; Nishioka, D.; Marcell, V.; Raymond, E.; Davidson, K.K.; Lawrence, R.A.; Wheelhouse, R.T.; Hurley, L.H.; Wu, R.S.; Von Hoff, D.D. Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos. Anti-Cancer Drug Des. 1999, 14, 355.
30. Han, F.X.; Wheelhouse, R.T.; Hurley, L.H. Interactions of TMPyP4 and TMPyP2 with Quadruplex DNA. Structural Basis for the Differential Effects on Telomerase Inhibition. J. Am. Chem. Soc. 1999, 121, 3561.
31. Siddiqui-Jain, A.; Grand, C.L.; Bearss, D.J.; Hurley, L.H. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 11593.
32. Rattner, J.B. Mapping the mammalian intercellular bridge. Cell Motil. Cytoskeleton 1992, 23, 231.
33. Carroll, J.S.; Swarbrick, A.; Musgrove, E.A.; Sutherland, R.L. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: Implications for the antiproliferative effects of antiestrogens. Cancer Res. 2002, 62, 3126.
34. Grand, C.L.; Han, H.; Muñoz, R.M.; Weitman, S.; Von Hoff, D.D.; Hurley, L.H.; Bearss, D.J. The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse trariscriptase expression and inhibits tumor growth in vivo. Mol. Cancer Ther. 2002, 1, 565.
35. Seenisamy, J.; Bashyam, S.; Gokhale, V.; Vankayalpati, H.; Sun, D.; Siddiqui-Jain, A.; Streiner, N.; Shin-ya, K.; White, E.; Wilson, W.D.; Hurley, L.H. Design and synthesis of an expanded porphyrin that has selectivity for the c-MYC G-quadruplex structure. J. Am. Chem. Soc. 2005, 127, 2944.
36. Kim, M.-Y.; Vankayalapati, H.; Shin-ya, K.; Wierzba, K.; Hurley, L.H. Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex. J. Am. Chem. Soc. 2002, 124, 2098.
37. Hurley, L.H. Secondary DNA structures as molecular targets for cancer therapeutics. Biochem. Soc. Trans. 2001, 29, 692.
38. Herbert, B.; Pitts, A.E.; Baker, S.I.; Hamilton, S.E.; Wright, W.E.; Shay, J.W.; Corey, D.R. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 14276.
39. Zhang, X.; Mar, V.; Zhou, W.; Harrington, L.; Robinson, M.O. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev. 1999, 13, 2388.
40. Mattern, K.A.; Swiggers, S.J.; Nigg, A.L.; Lowenberg, B.; Houtsmuller, A.B.; Zijlmans, J.M. Dynamics of protein binding to telomeres in living cells: Implications for telomere structure and function. Mol. Cell Biol. 2004, 24, 5587.
41. Karlseder, J. Telomere repeat binding factors: keeping the ends in check. Cancer Lett. 2003, 194, 189.
42. Lei, M.; Podell, E.R.; Cech, T.R. Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection. Nat. Struct. Mol. Biol. 2004, 11, 1223.
43. van Steensel, B.; Smogorzewska, A.; de Lange, T. TRF2 protects human telomeres from end-to-end fusions. Cell 1998, 92, 401.
44. Veldman, T.; Etheridge, K.T.; Counter, C.M. Loss of hPot1 function leads to telomere instability and a cut-like phenotype. Curr. Biol. 2004, 14, 2264.